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Abstract 
Bioactive glass coatings with thermal expansion coefficients matched to Ti6Al4V alloys have been 
designed, and glasses based on the multicomponent system 49.96 SiO2-7.25 MgO-3.30 Na2O-
3.30 K2O-3.00 ZnO-1.07 P2O5-32.62 CaO (mol%) with 0, 10, 25, 50, 75 and 100% of calcium oxide 
replaced by strontium oxide have been produced by a melt-quench route. Sintering behaviour has been 
characterised by differential scanning calorimetry, X-ray diffraction and scanning electron microscopy. 
Glass transition and crystallisation temperatures and their respective activation energies were 
determined; extrapolated onset values for these parameters have been determined in order to optimise 
the sintering temperature for producing amorphous coatings. Amorphous coatings have been produced 
which showed good adhesion to the alloy with the exception of the 100% Sr substituted coating. 
Substituting strontium for calcium reduced the glass transition temperature and lowered the activation 
energy for crystallisation whilst increasing the onset temperature of crystallisation. The mixed 
calcium/strontium glasses exhibit a larger processing window, which favours sintering without 
crystallisation occurring and obtaining amorphous well sintered coatings. However, complete 
substitution favours crystallisation and reduces the processing window.  
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1. Introduction 
The requirement for prosthetic metallic implants continues to grow as people live longer and more 
people are injured from physical activity and physical trauma. Metal alloys used in hip replacements do 
not bond or integrate well with bone, and therefore bioactive coatings are of interest to improve implant 
performance. Bioactive glasses, which degrade in the human body forming an apatite surface layer, 
were shown to form an integrated bond to mineralised tissue [1,2]. They were first developed by Hench 
in the late 1960s, and one intended application was for coating the femoral stem of hip prostheses for 
cementless fixation. The purpose of the bioactive glass coating was to promote osseointegration in 
order to provide a bond between prosthesis and bone. The procedure involved dip coating the 
prosthesis into the molten liquid glass at very high temperatures. However, satisfactory adhesion 
between the metal prosthesis and the bioactive glass was not achieved as a result of the large difference 
in the thermal expansion coefficient, TEC, between the glass and the metal [3]. 
The importance of matching the TEC of the glass to the alloy used for prosthesis has largely been 
neglected in most of the published studies of bioactive glass coatings on alloys used for medical 
prostheses. The studies by Gomez-Vega et al. [4,5] are a notable exception: the authors clearly 
recognise the importance of matching the TEC of the glass to the metal in their studies of bioactive 
glass coatings on Ti6Al4V alloys. Furthermore, Gomez-Vega et al. advocated an approach based on 
enamelling involving the sintering of glass particles at a temperature between the glass transition and 
crystallisation onset of a deposited coating. 
The commercially available 45S5 bioactive glass (Bioglass®) consisting of 46.1 SiO2-2.5 P2O5-
26.9 CaO-24.4 Na2O (mol%) has not only too high a TEC for enamelling Ti6Al4V (16 x10-6K-1 and 8-
10 x10-6K-1, respectively) but also crystallises almost immediately after heating above the glass 
transition temperature [6], which has two major drawbacks: a) it inhibits sintering by a high 
temperature viscous flow mechanism and b) any crystallisation will inherently reduce bioactivity in 
vivo. Both these aspects were recognised by Gomez-Vega et al. [4,5], and they clearly set out most but 
not all of the material design requirements and processing conditions for successfully producing 
bioactive glass coatings on Ti6Al4V alloy. These are summarised as follows: 
i) A TEC match of the glass to the Ti6Al4V alloy; we propose that the glass has a slightly 
higher TEC than the metal substrate so the coating is in compression. 
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ii) The coating must be sintered below the α?β phase transition temperature of Ti6Al4V 
alloy (≈980oC) in order not to compromise the mechanical properties and the fatigue life 
due to the large thermal expansion change in the alloy at this point. 
iii) The coating must be sintered well below the onset temperature for crystallisation; we 
propose that ideally the working range of the glass (Tc-Tg) > 100°C. 
iv) The coating must be sintered in an oxygen free (i.e. vacuum or noble gas) environment to 
prevent excessive oxidation of the Ti6Al4V alloy and remove any bubbles from the 
interfacial region and bulk of the coating. 
v) The glass must be bioactive (form a HCA layer in SBF in less than 4 weeks according to 
ISO 23317). 
Gomez Vega et al. [4,5] successfully produced well bonded glass coatings on Ti6Al4V alloys; 
however, they failed to recognise the importance of the network connectivity (NC) [7] of the glass in 
determining bioactivity, with the result that their coatings which bonded to Ti6Al4V had far from 
optimal bioactivity [5]. The authors resorted to adding hydroxyapatite or 45S5 Bioglass® particles to 
the coating surface to alleviate this problem, and more recently they have advocated the use of bi-layer 
coatings [8,9]. 
The bioactivity of glasses is strongly correlated with their NC [7,10] defined here as the average 
number of bridging oxygens (BOs) per silicon in the glass network. The network connectivity may be 
calculated according to Hill [7], but it is now recognised that phosphate in bioactive glasses does not 
form part of the silicate network [10,11] and is thought to exist as a distinct orthophosphate droplet 
phase [12], and due allowance must be made for this in the calculation of NC as well as in the 
calculation of the TEC. We assume that by analogy with sodium borosilicate glasses of low borate 
content, such as Pyrex™, the TEC of the glass is determined solely by the matrix silicate phase. 
Recently Tilocca et al. [13-15] have simulated the structure of bioactive glasses using molecular 
dynamics modelling and emphasised the importance of the fragmented and discontinuous nature of the 
silicate network. They have also looked at the structural role of phosphate and found evidence for 
glasses with greater than 5 mol% P2O5 exhibiting amorphous phase separation into a silica rich and 
phosphate rich phase [15]. This was confirmed by solid-state 31P nuclear magnetic resonance (NMR) 
experiments, which showed an orthophosphate phase for all phosphate contents when NC<2.5 
[10,11,16]. 
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Furthermore it is now recognised that MgO [17] and ZnO [18] can act not only as network modifying 
oxides (which will form non-bridging oxygens, NBOs), but also enter the silicate network in highly 
disrupted bioactive glass formulations (which will reduce the number of NBOs due to the formation of 
[MgO4]2- complexes which require cations such as Na+ or Ca2+ to charge balance). This, too, must be 
allowed for in the calculation of NC, although it is difficult to predict the amount of Mg or Zn entering 
the network without structural investigations by e.g. solid-state NMR. Mg2+ and Zn2+ cations have 
similar ionic radii (0.78 Å for Mg2+ and 0.83 Å for Zn2+) and have charge to size ratios that put them at 
the boundary between being classified as network modifying and intermediate oxides [19]. It is also 
important to note that if these two species act as intermediate oxides they will become incorporated 
into the silicate chain structure and will act in an analogous fashion to co-monomers in organic 
polymers to suppress crystallisation. This is a particularly attractive feature since highly disruptive 
bioactive glasses will generally crystallise readily.  
As a general rule the bioactivity is negligible or extremely low in glasses with NC values above 2.4, 
and it increases as NC is reduced towards a value of 2.0, which corresponds to a linear Q2 silicate 
structure where each silicon has on average two BOs and two NBOs [10]. Therefore an additional 
criterion for designing bioactive glass coatings is that the glass must have a NC < 2.4 and preferably as 
close to 2.0 as possible. In contradiction to the mechanisms proposed by Hench [2], it is important to 
note that dissolution and bioactivity are controlled by NC, and that the mechanism of dissolution and 
bioactivity involves little or no alkaline hydrolysis of Si-O-Si bonds, but instead involves the congruent 
dissolution of the glass as suggested by Hill [7]. This view is supported by unpublished experimental 
results which show the absence of a mixed alkali effect with regard to dissolution and bioactivity in 
mixed-alkali bioactive glasses, and the observation that the activation for alkali metal ion hopping from 
dielectric measurements is at least a factor of four higher than that for dissolution. 
In order to facilitate sintering and aid processing of coatings, a large temperature difference between 
the glass transition temperature (Tg) and the onset temperature for crystallisation (To) is required in the 
differential scanning calorimetry (DSC) trace of a glass powder suitable for sintering. Fig. 1a shows the 
DSC trace of the well-known 45S5 Bioglass® composition, and the DSC trace for a glass that is much 
more suitable for sintering is shown in Fig. 1b. Fig. 1b shows a much larger temperature difference 
between Tg and To, and this temperature difference we will refer to subsequently as the processing 
window. 
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Crystallisation of bioactive glasses is widely regarded as being undesirable [2,20,21] since 
crystallisation will occur predominantly at the surface of bioactive glass particles and will thus reduce 
the volume fraction of glass for viscous flow sintering. Furthermore, crystallisation inherently reduces 
bioactivity since crystal phases are in a lower energy state, the structure will be more tightly packed 
and the bonding will be stronger than the equivalent glass composition, and as a consequence the 
crystal phase will be less soluble. 
 
Figure 1:  DSC traces with glass transition (Tg) and onset peak crystallisation (To) temperatures and 
sintering window for (a) Bioglass® 45S5 and (b) glass 100% Sr. (Dotted lines are drawn 
as a guide to the eye.) 
We designed bioactive glass coatings based on the multicomponent system 49.46 SiO2-1.07 P2O5-
(32.62-×) CaO-× SrO-7.25 MgO-3.00 ZnO-3.30 Na2O-3.30 K2O with thermal expansion coefficients 
matched to Ti6Al4V alloys. Strontium was substituted for calcium in increasing amounts to provide 
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localised release of Sr2+ from the glass, as it was shown that strontium has the ability to stimulate the 
formation of new bone tissue and decrease bone resorption, and strontium also is the active ingredient 
in a new drug for osteoporosis treatment [22,23]. We were interested to see how strontium substitution 
for calcium affects glass sintering and crystallisation behaviour.  
2. Experimental  
2.1. Glass design 
The base glass composition, which is strontium-free (Table 1), was designed on the basis of its TEC 
calculated by means of Appen factors [24] and the calculated glass transition temperatures based on the 
paper by Andersson [25] with the objective of having a TEC close to the upper value for Ti6Al4V alloy 
of 10×10-6K-1and having as low a Tg as possible. For this purpose it is assumed that phosphorus is not 
part of the silicate glass network but exists as a separate orthophosphate phase dispersed in a silicate 
glass matrix phase. The level of phosphate is also low in these glasses and will not significantly 
contribute to the TEC. It is assumed that the TEC is determined by the composition of the silicate glass 
phase.  
In order to suppress crystallisation with the aim of having a large sintering window compared with 
Bioglass® 45S5, it was decided to increase the number of network modifying oxides in the composition 
to suppress the onset temperature for crystallisation. This increases the entropy of mixing and increases 
the barrier for crystallisation as the energy barrier for atomic rearrangement is higher to form critical 
size nuclei. The study by Aida showed that the optical basicity of the oxides (numerical expression of 
the average electron donor power of the oxide species) contributed to the thermal stability of oxide 
glasses. The combination of a high optical basicity alkali metal oxide (Na2O – 1.15) and a low optical 
basicity metal oxide (ZnO – 0.95) causes a strong interaction in the glass and suppresses the movement 
of Na+ and Zn2+ ions resulting in a high resistance to crystallisation [26]. 
 
Table 1: Glass compositions in mol%.  
Glass SiO2 P2O5 CaO SrO Na2O K2O MgO ZnO 
0% Sr 49.46 1.07 32.62 0 3.30 3.30 7.25 3.00 
10% Sr 49.46 1.07 29.36 3.26 3.30 3.30 7.25 3.00 
25% Sr 49.46 1.07 24.47 8.16 3.30 3.30 7.25 3.00 
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50% Sr 49.46 1.07 16.31 16.31 3.30 3.30 7.25 3.00 
75% Sr 49.46 1.07 8.16 24.47 3.30 3.30 7.25 3.00 
100% Sr 49.46 1.07 0 32.62 3.30 3.30 7.25 3.00 
 
Glasses incorporating both equal molar percentages of Na2O and K2O were produced. In addition, in 
order to reduce TEC and suppress crystallisation, MgO was also included, since it has been shown to 
act as an intermediate oxide and to suppress crystallisation [17]. ZnO was incorporated into the glass at 
3 mol% to further restrict the tendency towards crystallisation and to provide a small amount of Zn2+ 
release from the glass, which has well known bactericidal properties and is also important in wound 
repair and bone formation [27-29]. 
Finally SrO was included in the glass composition to provide localised Sr2+ release from the glass, as 
strontium is known to stimulate osteoblasts and inhibit osteoclasts [22,30,31]. In addition it has been 
shown recently that molar substitution of Ca by Sr in bioactive glasses increases the rate of dissolution 
of bioactive glasses by expanding the glass network and reducing the oxygen density of the glass [32]. 
2.2. Glass synthesis 
The glass compositions studied are given in Table 1 and consist of one series of glasses where SrO is 
substituted for CaO. The glasses were synthesised by mixing analytical grade silica (Prince Minerals 
Ltd., UK) with CaCO3, SrCO3, MgO, Na2CO3, K2CO3 and ZnO and P2O5 (all Sigma-Aldrich, UK) in 
the appropriate proportions, placing the mixed batch in a 300 mL platinum crucible and melting for 1.5 
hours at 1450°C in an electric furnace (Lenton EHF 17/3, UK). The glass was fritted by pouring into 
water, dried at 120°C overnight, then ground in a vibratory puck mill (Gyro Mill, Glen Creston, UK) 
for 14 minutes and sieved through a 20 µm sieve. Particle size of the fine powders for coatings was 
analysed using a laser particle size analyser (Cilas, UK).  
2.3. Glass characterisation 
The glass synthesised was analysed to understand how different percentages of Sr affect the glass 
properties. Techniques used were X-ray diffraction, differential scanning calorimetry and scanning 
electron microscopy. 
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2.3.1. X-ray diffraction (XRD) 
Each glass composition (as powder) and the coatings on Ti-alloy were studied using an X-ray powder 
diffractometer (Philips PW1700 series Automated Powder Diffractometer) with CuKα radiation 
(0.154056 nm) at 40 kV/40 mA with a secondary graphite crystal monochromator. The spectrum was 
taken in the 2θ range of 10º to 80º with a step size of 0.04º. 
2.3.2. Differential scanning calorimetry (DSC) 
50 mg of each glass sample powder was put in an inert platinum crucible and was analysed by DSC 
using analytical grade alumina powder as a reference material. The experiments were carried out in air, 
using a Stanton-Redcroft DSC 1500 (PL Thermal Sciences, Epsom, UK) at a constant heating rate of 
10 Kmin-1 up to a maximum temperature of 1050°C. The glass transition temperature (Tg), the peak 
crystallisation temperature (Tp) and the onset of crystallisation (To) were determined for each glass. 
The processing window was calculated as the difference between To and Tg. The tendency of the 
glasses to undergo surface nucleation was determined by performing DSC runs using two particle 
sizes: frit particles (approx. 1-2 mm) and fine powder (< 20 µm). 
Activation energies for crystallisation, Ea(Tp), were determined using the method outlined by Marrotta 
et al. [33]. The basis of the method is shown in equation 1: 
ln(β)=Ea/RTp+C (1) 
where β is the reciprocal of the heating rate, Ea is the activation energy of the process, Tp is the 
crystallisation peak temperature, R the universal gas constant (8.314 JK-1mol-1), and C is a constant. 
The activation energy can be obtained from linear interpolation if ln(β) is plotted against 1/Tp for 
varying heating rates (1/β). Five DSC heating rates of 5, 10, 15, 20 and 25 Kmin-1 were used for the 
analysis. The gradient of the line of best fit (m in y=mx+c) is equal to Ea/R. The activation energies for 
the onset temperature for crystallisation and the glass transition temperature (which is often correlated 
with that for viscous flow) were calculated in a similar manner.  
The activation energy plots were extrapolated to ln(β)=0 (i.e. the y-axis intercept), corresponding to a 
heating rate of 1 Kmin-1, to obtain values for the glass transition temperature and the onset temperature 
for crystallisation at a heating rate of 1 Kmin-1. These values are important because during the 
isothermal sintering temperature of the coatings the heating rate is 0 Kmin-1, and these values can be 
used to select the most appropriate sintering temperatures.  
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The value of the activation energy for viscous flow is important as it gives a measure of the ability of 
the glass to flow during sintering. The lower this value the easier the glass will be expected to undergo 
viscous flow sintering. In contrast, the activation energy for the onset temperature of crystallisation 
gives a measure of the energy barrier to crystallisation, and a high value is preferred. 
2.3.3. Scanning electron microscope (SEM) 
Fusibility of the glass, appearance of the coatings and adherence of the coatings to the alloy were 
analysed using a scanning electron microscope (JEOL 5610, Jeol Ltd., UK) at 15 keV with associated 
energy dispersive spectroscopy analysis (SEM-EDS). In order to look into the cross-section of the 
fabricated glass coating, the glass-coated alloy was mounted in a resin followed by grinding the cross-
section with 1200 grit SiC paper and polishing it with 1 µm diamond suspension. Line scans were 
performed for each glass cross-section sample with SEM-EDS. Line scan data was normalised by 
dividing the measurements by the average of each element. Diffusion coefficients were calculated from 
a least-squares fit of this complementary error-function (erfc) equation: 
N=N0erfc[x/(2Dt)0.5] (2) 
where N is the concentration of the element in question at distance x after time t from the concentration 
at x=0 (N0). 
2.3. Glass coatings  
Glass coatings on Ti6Al4V were produced by an enamelling technique. A sedimentation method was 
used to deposit bioactive glass onto the Ti6Al4V alloy. 9.43 g of the selected glass powder (particle 
size < 20 µm) were dispersed in 25 mL of ethanol by stirring thoroughly. A Ti6Al4V piece 
(5×5×1 mm), which had been previously polished with 1 µm diamond paper and cleaned in ethanol, 
was placed into the glass powder suspension. This was left in an oven at 80°C for 1.5 hrs so that the 
glass powders were deposited on the metal substrate, producing a uniform surface. Confirming that the 
glass powder was totally settled, the specimen was introduced into a porcelain furnace (Centurion 
Quartz, Dentsply Ceramco, York, PA, USA) that was pre-heated to 250°C. It was heated at a rate of 
60 Kmin-1 to 750°C followed by a 30 min hold at this temperature. This entire heating process was 
performed at 90 kPa vacuum.  
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3. Results  
3.1. Characterisation of glasses  
 
Figure 2:  X-ray diffraction patterns of the glasses after quenching, drying and milling. (Curves 
smoothed by 5-point adjacent average smoothing.) 
All compositions were obtained in a glassy state with the amorphous structure being confirmed by 
XRD (Fig. 2). The maximum in the amorphous scattering shifts to smaller 2θ values with increasing 
strontium substitution. DSC traces of all the glasses exhibited peak crystallisation temperatures that 
shifted to higher temperatures with increasing particle size, shown in Fig. 3 for glass 50% Sr. Table 2 
summarises the DSC results: extrapolated Tg values show a very slight general decrease with 
increasing strontium substitution (Fig. 4a) from 604°C (0% Sr) to 587°C (100% Sr). Crystallisation 
onset temperatures (To; Fig. 4a) decrease from 808°C (0% Sr) to 753°C (100% Sr); however, the 
reduction is not linear: To is approximately constant for the 0% Sr and the 50% Sr glasses but reduces 
significantly for the 100% Sr glass to 753°C. Processing windows (Fig. 4b) are between 200 and 240 K 
for all compositions apart from glass 100% Sr, which gave a processing window of 166 K. The 
processing window seems to increase linearly for glasses with 0, 25, 50 and 75% strontium 
substitution; however, the processing window of glass 10% Sr does not follow the same trend and is 
considerably larger (238 K) than those of all other glasses in the series. Activation energies (Ea) for 
glass transition and crystallisation temperatures are shown in Fig. 5. The activation energy for the glass 
transition temperature falls from 370 kJmol-1 (0% Sr) to 325 kJmol-1 (100% Sr) with increasing 
strontium content. Activation energy for To decreased from 346 kJmol-1 (0% Sr) to 208 kJmol-1 
(100% Sr), and activation energy for Tp decreases from 344 kJmol-1 (0% Sr) to 280 kJmol-1 (100% Sr, 
Fig. 5). Again, glass 10% Sr does not follow the same trend and gives considerably higher activation 
energies.  
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Figure 3:  DSC traces of glass 50% Sr for fine particles (< 20 µm) and frit (about 1-2 mm) at a 
heating rate of 10 Kmin-1. 
Table 2: Summary of DSC results (Ea: activation energy; To-Tg: processing window; Tg0 and To0 are 
extrapolated values.) 
%Strontium Tg0 
(°C) 
Ea(Tg) 
(kJmol-1) 
To0 
(°C) 
Ea(To) 
(kJmol-1) 
Ea(Tp) 
(kJmol-1) 
To-Tg 
(°C) 
0% Sr 604 -370 808 -346 -344 204 
10% Sr 580 -350 818 -527 -413 238 
25% Sr 597 -351 806 -238 -295 209 
50% Sr 590 -320 807 -246 -233 217 
75% Sr 572 -340 793 -245 -300 221 
100% Sr 587 -325 753 -208 -280 166 
 
3.2. Characterisation of coatings  
XRD patterns of the coatings sintered at 750°C for 30 min are shown in Fig. 6a, and they confirm that 
the coatings (except for 100% Sr) are amorphous. There is a small diffraction peak at 2θ = 38° for 
10%, 25% and 50% strontium substituted glasses, but this corresponds to a diffraction line in the 
Ti6Al4V alloy and arises from the fact that X-rays are being diffracted from the alloy substrate beneath 
the glass coating. XRD of the 100% Sr coating sintered at 800°C for 0.5 hrs showed it to be highly 
crystalline (Fig. 6b). However, the crystal phases formed did not match any known crystalline phase. 
We therefore heat treated glass powder (0% Sr, 50% Sr and 100% Sr) at 900°C and performed x-ray 
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diffraction. Fig. 7 shows the XRD patterns of the heat treated glass powders at 900°C; crystal phases 
are wollastonite (CaSiO3, JCPDS 27-0088; 0% Sr) and strontium silicate (SrSiO3, JCPDS 34-0099; 
100% Sr). The peaks of the 50% Sr composition did not match any known crystal phases, but are 
similar to the ones for 100% Sr (strontium silicate) but shifted to higher 2θ values on the x-axis.  
 
Figure 4:  (a) Extrapolated values Tg0 and To0 and (b) processing window vs. strontium substitution 
for calcium (in %). (Lines are drawn as a guide to the eye.) 
An SEM micrograph of 50% Sr glass powder is presented in Fig. 8a; particle size distribution values 
are shown in Table 3. Mean diameter and 50% diameter differ considerably which suggests that the 
particle size distribution is non-Gaussian. The glass particles are angular with relatively sharp edges. 
The 50% particle size distribution was around 2.7 µm which is in agreement with the SEM 
micrographs.  
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Table 3:  Particle size distribution values and mean for 0%, 10%, 50% Sr glass particles. 
Glass 
Diameter 10% 
µm 
Diameter 50% 
µm 
Diameter 90% 
µm 
Mean diameter 
µm 
0% Sr 0.68 2.66 17.76 6.33 
10% Sr 0.65 2.69 16.81 5.91 
50% Sr 0.69 2.72 17.90 6.60 
 
SEM investigation of 50% Sr coatings after sintering contained few pores and little evidence of any 
remnants of the original glass particles (Fig. 8b). In addition, no cracks were observed on the surface of 
the coating sintered at 750°C. It can be seen that the surface of 100% Sr coating (Fig. 8c and d) 
contains pores and bubbles; at a low magnification several cracks were observed (Fig. 8c). SEM results 
(back scattered electron mode) presented in Fig. 9 show cross-sections of 50% Sr and 100% Sr glass 
coatings on Ti-alloy fired at 750°C: a 120 µm thick glass coating can be seen to be well attached to the 
Ti6Al4V substrate for the 50% Sr glass, whereas a gap and cracks are clearly observed between 
100% Sr glass and the Ti-alloy substrate. Delamination of the 100% Sr coating occurred readily.  
An elemental line scan was performed along the 50% Sr glass coating and the results indicate that the 
coating was homogeneous as the elemental concentrations remained constant throughout the scan as 
(Fig. 10). Fig. 11 illustrates a line scan performed across the Ti-alloy/glass interface: The results show 
sigmoidal curves of decreasing Ti, Al and V concentrations and sigmoidal curves of increasing 
concentrations for the elements comprising the glass composition over a distance of 5 to 10 µm as 
expected. Diffusion coefficients are shown in Table 4.  
 
Figure 5:  Activation Energy (Ea) for glass transition (Tg), onset peak crystallization (To) and peak 
crystallization (Tp) vs. strontium substitution for calcium (in %). (Lines are drawn as a 
guide to the eye.)  
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Table 4: Diffusion coefficients for 50% strontium glass coated onto Ti6Al4V. 
Element D (×10-15 m2.s-1) 
Glass 
Si 6.49 
Na 2.47 
K 3.09 
Ca 3.85 
Sr 0.90 
Mg 1.94 
Zn 2.01 
P 0.99 
O 9.36 
Metal 
Ti 8.69 
V 9.72 
Al 5.79 
 
4. Discussion 
4.1. Characterisation of glasses  
Upon introduction of strontium into the glasses, the maximum of the amorphous halo in XRD patterns 
was found to shift progressively to smaller 2θ values (i.e. larger d-spacing) with increasing strontium 
substitution, indicating an expansion of the glass network on incorporating strontium. Fredholm et al. 
[32] found a similar result with strontium substituted bioactive glass compositions along with a 
reduction in oxygen density and an increase in molar volume of the glass. The Sr2+ cation is slightly 
larger than Ca2+ cation (1.16 Å for Sr2+ and 0.94 Å for Ca2+) resulting in it attracting non-bridging 
oxygens less, which is thought to result in the expansion of the glass network. 
The DSC traces of all the glasses exhibited peak crystallisation temperatures (Tp) that shifted to higher 
temperatures with increasing particle size, indicating a surface induced nucleation process. This 
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phenomenon appears to be a characteristic of bioactive glasses. It has been observed in a number of 
previous studies [10,34] and is related to the particle size effects on heat transfer [35].  
 
Figure 6:  X-ray diffraction patterns of (a) bioactive glass coatings on Ti6Al4V alloy and uncoated 
Ti6Al4V alloy as control (sample 10% Sr was run using an increased count rate per step; 
all curves smoothed by 5-point adjacent average smoothing) and (b) a delaminated piece 
of 100% Sr coating heat-treated at 800°C.  
Extrapolated Tg values showed a slight general decrease with increasing strontium substitution. 
Similarly, activation energy for Tg decreases with increasing strontium content. The activation energy 
for the glass transition temperature is often associated with that for viscous flow; a lower value is 
therefore likely to give rise to more efficient sintering for a given particle size distribution. 
Extrapolated To values decrease with increasing strontium content, and activation energies for both To 
and Tp show a slight overall decrease with increasing strontium substitution. There are probably two 
factors influencing the results: On substituting Sr for Ca the glass network will become weaker, and it 
would be expected that the glass would be able to rearrange to the crystalline state more readily as a 
Lotfibakhshaiesh et al.:  Bioactive glass coatings for Ti6Al4V alloy 17/22 
 Journal of Non-Crystalline Solids 356 (2010) 2583–2590 
result. Opposing this is that incorporating Sr into an all Ca glass would be expected to increase the 
entropy of mixing and stabilise the disordered glass state. We would therefore expect the 100% Sr 
substituted glass to crystallise more readily than any of the other glasses and to exhibit the lowest 
activation energies for Tg, To and Tp. Our results show that this glass, indeed, crystallises at a 
significantly lower temperature than the other glasses and gives the smallest processing window. 
 
Figure 7:  X-ray diffraction patterns of glass powder 0% Sr, 50% Sr and 100% Sr heat-treated at 
900°C. Crystal phases are × wollastonite (CaSiO3) and + strontium silicate (SrSiO3). 
All glasses in this series show a processing window significantly increased compared to Bioglass® 
45S5 (Fig. 1a). This makes 45S5 challenging to sinter above Tg without some crystallisation occurring 
by conventional enamelling techniques. The processing window in our series increases slightly with 
increasing strontium substitution for calcium, but decreases by over 50 K for the 100% strontium 
substituted glass, largely as a result in the reduction in To. We should therefore expect glass 100% Sr to 
be the most difficult to sinter without crystallisation occurring.  
3.2. Characterisation of glass coatings on Ti- alloy 
According to the DSC results, of all the compositions studied the 100% strontium substituted glass 
should be the most difficult to sinter without crystallisation occurring. The sintering temperature of 
750°C is very close to the crystallisation onset of glass 100% Sr (753°C). However, lowering the 
temperature of sintering of the 100% Sr glass resulted in opaque white but amorphous coating that had 
not sintered fully and scattered light as a result of a significantly high residual porosity in the coating 
(resuls not shown). XRD patterns of the coatings sintered at 750°C for 30 min show a typical 
amorphous halo except for glass 100% Sr, which gave crystalline peaks. Due to the small number and 
low intensity of the peaks, they were difficult to assign to a crystal phase. The delaminated 100% Sr 
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coating was therefore heat treated at 800°C for 30 min; XRD showed it to be highly crystalline. 
However, the diffraction pattern did not match any known crystal phase, even if presence of elements 
from the alloy (titanium, aluminium or vanadium) was considered. This might be caused by the fact 
that the peaks are shifted slightly, most likely a result of the non-stoichiometry of the interfacial region 
or of formation of mixed cation phases in this multi-component system.  
 
Figure 8: SEM micrograph (secondary electron mode) of (a) 50% Sr glass powder, (b) 50% Sr 
coated surface produced by enamelling, (c),(d) 100% Sr coating with (c) overview with 
crack and pores and (d) bubbles and pores at higher magnification. 
XRD patterns of glass powder heat treated at 900°C correspond to wollastonite (calcium silicate, 
CaSiO3, glass 0% Sr) and strontium silicate (SrSiO3, glass 100% Sr). The pattern of heat treated 
50% Sr powder is most likely to be a mixed calcium strontium silicate, where the differences in ionic 
radii of Sr2+ and Ca2+ caused a shift in peak positions in XRD patterns compared to that of SrSiO3 
(100% Sr glass).  
SEM micrographs of 50% Sr sintered coatings shows that the thermal expansion of glass and Ti-alloy 
are well matched and that the viscous flow sintering process has occurred efficiently. Glass 100% Sr, 
on the other hand, is less suitable for coating using an enamelling technique due to the reduced 
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processing window compared to the other glasses in the series as shown above. This results in partial 
crystallisation of the coating as well as poor adhesion and delamination.  
 
Figure 9: SEM images (backscattered electrons) of cross-sections of (a) 50% Sr and (b) 100% Sr 
coatings on Ti-alloy. 
 
Figure10: Line scan profile of 50% Sr glass coating. 
The elemental line scan across the Ti-alloy/glass interface shows sigmoidal curves of decreasing Ti, Al 
and V concentrations and increasing concentrations of the elements comprising the glass composition. 
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A sigmoidal curve represents a classical diffusion profile in both alloy and glass composition: 
Diffusion rates of the alloy species (Ti, Al and V) dropping off to zero around 5 to 10 μm into the 
coating. This can be reduced further by reducing the sintering temperature and/or time.  
SEM and XRD characterisation of the coatings confirmed a coherent interface between Ti6Al4V and 
glass, with no obvious crystallisation at the interface, and no Al, Ti or V was detected in the glass away 
from the interfacial region. There were very few pores or bubbles in the sintered coatings indicating 
that the sintering had been efficient. 
 
Figure11: Line scan profile across the interface between Ti-alloy and 50% Sr glass coating: (a), (b) 
SEM micrograph of area of scan and (c) normalised element concentrations.  
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4. Conclusion 
Bioactive glass coatings with a thermal expansion coefficient matched to Ti6Al4V alloy have been 
produced. Processing windows (i.e. the temperature range between glass transition temperature and the 
onset of crystallisation) are significantly increased compared to Bioglass® 45S5. Substituting strontium 
for calcium in the glass composition reduces the glass transition temperature and lowers the activation 
energy for crystallisation whilst increasing the onset temperature of crystallisation. The mixed 
calcium/strontium glasses exhibit a larger processing window (200 K and more), which favours 
sintering without crystallisation occurring to obtain amorphous well sintered coatings. However the 
glass with complete strontium substitution favours crystallisation due to a smaller processing window.  
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